These therapeutic options can be used for weight control in patients with immune-mediated dermatosis who meet the above criteria
Common Gastrointestinal Side Effects Gastrointestinal symptoms represent the most frequent adverse events with Retatrutide, consistent with other GLP 1 class medications
In recent years, an increasing number of previously unknown molecular markers specific to distinct islet cell types have been described
For example, patients may continue using retinoids, antioxidants, or hair growth medications alongside peptides
[1] For weight management, tirzepatide is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity, and must be used in conjunction with a reduced-calorie diet and increased physical activity
In murine models, GLP-1 levels rose rapidly in response to gut barrier injury, suggesting a role in acute intestinal restitution (54)